VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
Public ClinicalTrials.gov record NCT00291187. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 and Matching Placebo in Healthy Male and Female Subjects With Induced Transient Insomnia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.
Study identification
- NCT ID
- NCT00291187
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 411 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Aug 2006 (Actual)
- Completion
- Aug 2006 (Actual)
- Last update posted
- Oct 15, 2014
2006
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Birmingham | Alabama | — | — |
| Vanda Investigational Site | Phoenix | Arizona | — | — |
| Vanda Investigational Site | San Diego | California | — | — |
| Vanda Investigational Site | San Francisco | California | — | — |
| Vanda Investigational Site | Santa Monica | California | — | — |
| Vanda Investigational Site | Miami | Florida | — | — |
| Vanda Investigational Site | Naples | Florida | — | — |
| Vanda Investigational Site | Pembroke Pines | Florida | — | — |
| Vanda Investigational Site | St. Petersburg | Florida | — | — |
| Vanda Investigational Site | Atlanta | Georgia | — | — |
| Vanda Investigational Site | Overland Park | Kansas | — | — |
| Vanda Investigational Site | Chevy Chase | Maryland | — | — |
| Vanda Investigational Site | New York | New York | — | — |
| Vanda Investigational Site | Rochester | New York | — | — |
| Vanda Investigational Site | Raleigh | North Carolina | — | — |
| Vanda Investigational Site | Cincinnati | Ohio | — | — |
| Vanda Investigational Site | Columbia | South Carolina | — | — |
| Vanda Investigational Site | Austin | Texas | — | — |
| Vanda Investigational Site | Plano | Texas | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00291187, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2014 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00291187 live on ClinicalTrials.gov.